Multiple Myeloma News & Features
The molecular mail sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study presented at ASH. The findings may ultimately guide doctors in deciding which therapies are best for individual patients with myeloma.
Improved progression-free survival in relapsed multiple myeloma has been seen with the addition of carfilzomib to lenalidomide and dexamethasone therapy.
Recent therapeutic progress has improved outcomes for patients with myeloma; however, the complex biology of this disease continues to challenge treatment.
A new drug in development, known as DTP3, has killed myeloma cells in laboratory tests in human cells and mice.
Researchers believe that a staple of Earth science research can be used in biomedical settings to predict the course of disease.
Multiple Myeloma Clinical Trials
- Colorectal cancer incidence is increasing among young adults
- Study examines vaccine therapy in prostate cancer with rising prostate-specific antigen (PSA) levels
- Nutrition education may help prevent breast cancer recurrence
- New study helps physicians and patients determine prostate cancer risk
- E-cigarettes declared a health threat by California health officials
- Oncology patient navigation: Bringing this crucial role to the forefront
- Radiation plus hormone therapy prolongs survival for older men with prostate cancer
- Mistletoe: The holiday plant is making headlines as an alternative cancer treatment
- Using genomic correlates of radiotoxicity to predict patient outcomes
- Therapy dogs may encourage cancer patient to persevere with treatment
- Cancer biopsies found not to promote cancer spread
- Effectiveness of nanoparticle drugs was hindered by tumor microenvironment in triple-negative breast cancer
- Cancer diagnoses diminishes adherence to diabetes medications
- Consideration of comorbidity in cancer treatment decision-making in multidisciplinary team meetings
- Moderate lifetime marijuana smoking not associated with lung function decline
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|